Amoéba Publishes Half-Year Financial Report for 2026

Amoéba, a greentech company based in Chassieu, France, has released its half-year financial report for the period ending June 30, 2026. The report was filed with the French Financial Markets Authority (AMF) and is accessible on the company's website. The financial statements, approved by the Board on October 29, 2026, were reviewed by auditors with no amendments or observations. The figures remain consistent with the preliminary statements from September 2026.

Amoéba focuses on microbiological risk management using amoebae in plant protection and cosmetics. The company secured regulatory approvals for its biocontrol product AXPERA in the U.S. in 2025 and France in 2026, aiming for broader European distribution. For cosmetics, the ingredient is listed on the INCI, facilitating global marketing except in China.